Chen Szu-Yu, Mahabole Megha, Horesh Elan, Wester Sara, Goldberg Jeffrey L, Tseng Scheffer C G
TissueTech, Inc., Miami, Florida, United States.
University of Miami Miller School of Medicine, Miami, Florida, United States.
Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):4842-52. doi: 10.1167/iovs.14-14441.
Adipose-derived stem cells (ASCs) have gained importance due to their myriad potential clinical applications. We hypothesize that progenitor cells also exist besides those conventionally isolated from the stromal vascular fraction (SVF).
Central and medial orbital adipose tissues obtained from patients during eyelid surgery were digested with collagenase for 3 or 16 hours at 37°C with or without shaking. After centrifugation, the remaining cell pellet was resuspended and filtered to yield flow through in SVF and retained cells (RC) on the filter. Single cells from RC and SVF were cultured on 5% coated Matrigel in serum-free modified embryonic stem cells medium (MESCM) for 10 passages. The progenitor status was evaluated by the expression of a number of markers by qPCR and immunofluorescence staining as well as their plasticity for endothelial and tri-lineage differentiation.
Type I collagenase digestion for 3 hours under shaking was significantly less effective in releasing progenitor cells than collagenase A digestion for 16 hours without shaking. Following filtration, cells in SVF and RC, of which the latter were tangled in collagen IV-containing matrix, expressed different markers of progenitor cells. Cells from SVF and RC could be expanded for 10 passages on coated Matrigel in MESCM and exhibited similar or better potential to differentiate into vascular endothelial cells, chondrocytes, osteocytes, and adipocytes than SVF cells expanded on plastic in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS).
Different progenitor cells can be isolated and expanded from orbital adipose tissues. Further characterization of their mesodermal or neuroectodermal origin might enhance clinical outcome when used as a source of autologous stem cells for ocular surface regeneration.
脂肪来源干细胞(ASC)因其众多潜在的临床应用而变得重要。我们假设,除了那些传统上从基质血管成分(SVF)中分离出来的细胞外,还存在祖细胞。
在眼睑手术期间从患者获取的眶中央和内侧脂肪组织,用胶原酶在37℃下消化3或16小时,消化过程中有或没有振荡。离心后,将剩余的细胞沉淀重悬并过滤,以得到SVF中的滤液和过滤器上保留的细胞(RC)。将来自RC和SVF的单细胞在5%包被的基质胶上,于无血清改良胚胎干细胞培养基(MESCM)中培养10代。通过qPCR和免疫荧光染色检测多种标志物的表达,以及它们向内皮细胞和三系分化的可塑性,来评估祖细胞状态。
与在无振荡条件下用胶原酶A消化16小时相比,在振荡条件下用I型胶原酶消化3小时,在释放祖细胞方面的效果明显较差。过滤后,SVF和RC中的细胞表达了不同的祖细胞标志物,其中RC细胞纠结在含IV型胶原的基质中。来自SVF和RC的细胞能够在MESCM中的包被基质胶上扩增10代,并且与在含10%胎牛血清(FBS)的杜氏改良 Eagle培养基(DMEM)中在塑料上扩增的SVF细胞相比,它们在分化为血管内皮细胞、软骨细胞、骨细胞和脂肪细胞方面表现出相似或更好的潜力。
可以从眶脂肪组织中分离并扩增不同的祖细胞。当用作眼表再生的自体干细胞来源时,进一步表征它们的中胚层或神经外胚层起源可能会改善临床结果。